Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy. - Fallowfield, L; Gagnon, D; Zagari, M; Cella, D; Bresnahan, B; Littlewood, T J; McNulty, P; Gorzegno, G; Freund, M; Epoetin Alfa Study Group (British Journal of Cancer, 2002)